This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Wakix

Grupo Ferrer Internacional, S.A.

Drug Names(s): BF2.649, BF2649, pitolisant, FUB-649

Description: BF2.649 is an inverse histamine H3-receptor agonist.

Deal Structure: Ferrer and BioProjet are co-developing tiprolisant.

Partners: BioProjet SCR


Wakix News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug